ATE98259T1 - Anf-derivate mit neuer verbrueckung. - Google Patents

Anf-derivate mit neuer verbrueckung.

Info

Publication number
ATE98259T1
ATE98259T1 AT88121106T AT88121106T ATE98259T1 AT E98259 T1 ATE98259 T1 AT E98259T1 AT 88121106 T AT88121106 T AT 88121106T AT 88121106 T AT88121106 T AT 88121106T AT E98259 T1 ATE98259 T1 AT E98259T1
Authority
AT
Austria
Prior art keywords
methylene
derivatives
des
independently
thio
Prior art date
Application number
AT88121106T
Other languages
English (en)
Inventor
Maio John Di
Dominik Marek Wernic
Jorge Jaramillo
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Application granted granted Critical
Publication of ATE98259T1 publication Critical patent/ATE98259T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88121106T 1987-12-16 1988-12-16 Anf-derivate mit neuer verbrueckung. ATE98259T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA000554516A CA1337891C (en) 1987-12-16 1987-12-16 Anf derivatives with novel bridging
EP88121106A EP0320967B1 (de) 1987-12-16 1988-12-16 ANF-Derivate mit neuer Verbrückung

Publications (1)

Publication Number Publication Date
ATE98259T1 true ATE98259T1 (de) 1993-12-15

Family

ID=4137086

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88121106T ATE98259T1 (de) 1987-12-16 1988-12-16 Anf-derivate mit neuer verbrueckung.

Country Status (7)

Country Link
US (1) US4891358A (de)
EP (1) EP0320967B1 (de)
JP (1) JPH01258698A (de)
AT (1) ATE98259T1 (de)
CA (1) CA1337891C (de)
DE (1) DE3886186T2 (de)
NZ (1) NZ227307A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT63859A (en) * 1990-10-11 1993-10-28 Boehringer Ingelheim Kg Process for producing cyclopeptides and pharmaceutical compositions comprising same
WO2018049071A1 (en) * 2016-09-07 2018-03-15 Vanderbilt University Vasoactive polypeptides for smooth muscle relaxation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618600A (en) * 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
WO1985004872A1 (en) * 1984-04-24 1985-11-07 The Salk Institute For Biological Studies Atrial peptide analogs
JPH0672157B2 (ja) * 1984-08-29 1994-09-14 味の素株式会社 新規ペプチド
US4670540A (en) * 1984-08-29 1987-06-02 Ajinomoto Co., Inc. Novel peptide
US4757048A (en) * 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
US4721704A (en) * 1986-05-09 1988-01-26 Peninsula Laboratories, Inc. Potent synthetic atrial peptide analogs
JPH01243100A (ja) * 1988-03-24 1989-09-27 Oki Electric Ind Co Ltd 音紋の照合方法

Also Published As

Publication number Publication date
AU607291B2 (en) 1991-02-28
US4891358A (en) 1990-01-02
EP0320967B1 (de) 1993-12-08
EP0320967A2 (de) 1989-06-21
AU2682488A (en) 1989-06-22
JPH01258698A (ja) 1989-10-16
EP0320967A3 (en) 1990-04-25
NZ227307A (en) 1991-02-26
DE3886186T2 (de) 1994-06-23
CA1337891C (en) 1996-01-02
DE3886186D1 (de) 1994-01-20

Similar Documents

Publication Publication Date Title
KR890000514A (ko) 트립신형 프로테아제의 펩타이드 붕산 억제제
FI943233A (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
DE69233068D1 (de) Serin-reiche peptidlinker
ES543258A0 (es) Procedimiento para la obtencion de derivados de diaminoaci- dos
DE69502539D1 (de) Sarpogrelat enthaltende opthalmologische Zubereitungen zur Senkung des intraokularen Druckes
KR900016238A (ko) 신규 화합물
AU1634388A (en) Cyclic anticoagulant peptides
DK0393934T3 (da) Nye peptider samt antidemensmidler indeholdende disse peptider
ES2084149T3 (es) Conjugados de hirudinpolialquilenglicol.
ATE98259T1 (de) Anf-derivate mit neuer verbrueckung.
AU1634288A (en) Cyclic anticoagulant peptides
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
NZ231636A (en) Anticoagulant peptides analogus to hirudins' active site
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
ATE82984T1 (de) Hemmende peptide.
DE69028953D1 (de) Antiherpes-Pentapeptide
ATE94168T1 (de) Peptide.
SE7909653L (sv) Tyrosylerade proinsulin c-peptidderivat
EP0190597A3 (de) Retro-Inverso-Analoga von Peptid BPP5a mit Bradykinin-Wirkung
SE9304291L (sv) Diagnostiskt antigen och förfarande för in vitro diagnostisering av en aktiv infektion förorsakad av hepatit C virus
RU93004870A (ru) Полипептид, способ его получения, способ ингибирования роста клеток и медикамент
SE8901278L (sv) Peptidderivat
HUP9601528A2 (hu) Véralvadásgátló hatású peptidszármazékok és a vegyületeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties